Rheumatoid arthritis (RA) 
Introduction
Rheumatoid arthritis(RA) is known to affect approximately 1% of the worldwide population. According to the National Health and Nutrition Survey in 2005, the incidence of RA in Korea was 21.1 per 1000 [1] . RA is a chronic disease that can lead to synovitis, consequently inducing joint deformity and damage. Diverse studies have suggested that the etiology of RA is multifactorial, involving various genetic and environmental factors, autoimmune functions, and pathogenic mediators. Unfortunately, RA is still characterized as a chronic disease of unknown etiology, and the complete cure for this disease is yet unclear.
Exercise contributes to maintaining health and is associated with significant increases in the function of the immune system and in biological activities [2] . The review article by Metsios et al. suggested that therapy with prescription and exercise was a potential intervention for improving RA [3] . Because the medications for RA consist of diseasemodifying anti-rheumatic drugs, biological response modifiers, glucocorticoids, and nonsteroidal anti-inflammatory medications, with the risk of adverse effects from longterm administrations, the treatment for RA requires more effective research for developing therapies with proven stability [4] .
Especially, natural compounds may improve the risk of adverse effects. Lonicerae flos(LF) has been commonly used as a tea material. Some studies showed that the diverse pharmacological actions of LF extract include anti-inflammatory, anti-oxidant, and anti-cancer effects. However, the effects of LF on RA mediation have not yet been established. Hence, we designed this study to determine whether LF can mitigate RA through the inhibition of cyclooxygenase(COX)-2 and matrix metalloproteinase(MMP)-9 by means of regulation of macrophage migration inhibitory factor(MIF).
Methods

Materials
All cell culture materials and the MTT assay kit were purchased from Sigma, Gibco BRL(Gaithersburg, MD, USA). Antibodies such as anti-COX-2 and anti-MMP-9 were purchased from Santa Cruz Biotechnology(Santa Cruz, CA, USA). All other chemicals were purchased from Sigma(St. Louis, MO, USA).
Design of experiments
To determine the effect LF in a collageninduced RA model, we performed reverse transcription polymerase chain reaction(RT-PCR), histological analysis, and immunohistochemistry.
Procedure
Cell isolation and culture
Infrapatellar fat pads(IFPs) were harvested from the knees of mice. Ten IFPs were minced and digested in 1 mg/mL collagenase(Wako, Osaka, Japan) for 15 min and passed through a 40-mm filter(Becton Dickinson, Franklin Lakes, NJ, USA). Dissociated cells and undigested IFPs were cultured together in a 100-mm culture dish. The mouse synovium cells(mSCs) were cultured in Dulbecco's modified eagle medium(DMEM) containing 10% fetal bovine serum and 1% penicillinstreptomycin at 37°C in a 5% CO2 atmosphere. Primary cells were seeded at 5 × 105 cells/well in six-well plates containing DMEM, and incubated for 24 h. Cells were incubated with different concentrations of LF(0.4, 0.6, 0.8, and -1.0 mg/mL) in phorbol 12-myristate 13-acetate(PMA)-free medium or PMAcontaining medium for 24 h.
RT-PCR
After cell culture, total RNA was isolated from cells by using TRI-reagent, and then cDNA was synthesized by using 1.0 µg total RNA in a Superscript II Reverse Transcription System. PCR amplification was performed with the following protocol: pre-denaturation at 95C for 3 min and then either 30 cycles of denaturation at 94C for 1 min, annealing at the melting temperature of each primer for 1 min, or extension at 72C for 1 min, followed by a final extension at 72C for 10 min. mRNA expression was quantified by using an ethidium bromide-stained 1.5% agarose gel. The following primers were used for the PCR reaction: MIF, sense primer 5'-CAC CAT GCC TAT GTT CAT CGT GAA CA-3', anti-sense primer 5'-GGG CTC AAG GCG AAG GTG GAA CCG TT-3'; COX-2, sense primer 5'-TCT CCA ACC TCT CCT ACT AC-3', anti-sense primer 5'-GCA CGT AGT CTT CGA TCA CT-3'; MMP-9, sense primer 5'-AAG CCT CTA CAG AGT CTT TG-3', anti-sense primer 5'-CAG TCC AAC AAG AAA GGA CG-3'; and β-actin, sense primer 5'-GGA GAA GAT CT GCA CCA CACC-3', antisense primer, 5'-CCT GCT TGC TGA TCC ACA TCTGCT GG -3'.
Animal care and analysis
The animals(DBA mice, 6 weeks; n = 20) were randomized into two groups: collageninduced arthritis(CIA) group(CE group) [5] and RA treated with LF group(LT group). LF was dissolved in water and administered to the LT group at 45 mg/kg orally for 28 days. Animal care and all experiments were conducted in conformity with the institutional guidelines of Pusan National University(Institutional Animal Care and Use Committee no. PNU-2016-1290), South Korea, and conformed to the Guide for the Care and Use of Laboratory Animals from the US National Institutes of Health(publication no. 85-23, revised 2011). Segments from each half were embedded in paraffin, and 5-m sections were prepared, cleared with xylene, and hydrated with ethanol. The sections were stained with hematoxylin and eosin and observed with a BX51 light microscope. The slides with sections were treated with avidin-biotin block, exposed to diaminobenzidine with hematoxylin, and analyzed under a light microscope.
Statistical analysis
The results are expressed as the mean ± standard error of at least three independent experiments. The difference between the two groups was examined by using Student's ttest. A p-value of <0.05 was considered statistically significant. Statistical analysis was carried out with GraphPad Prism 4.0 software.
Results
LF attenuates the expression of MIF, COX-2, and MMP-9 in PMA-stimulated mSCs
As shown in <Figure 1>, PMA(1 ng/mL) significantly increased the expression levels of MIF, COX-2, and MMP-9 in mSCs. In contrast, this enhanced expression of MIF, COX-2, and MMP-9 was inhibited by treatment with LF(0.4-1.0 mg/mL) in a concentration-dependent manner. The expression levels of MIF, COX-2, and MMP-9 showed a maximal response at 1 mg/mL LF. 
LF reduces damage in CIA-induced RA mice
As shown in <Figure 2>, LF(45 mg/kg) administration significantly reduced the synovial cell hyperplasia in the CIA-induced RA model <Figure 2A>. Moreover, LF administration reduced the fibrosis in the CIA-induced RA model <Figure 2B>. 
LF modulates the expression of MIF, COX-2, and MMP-9 in CIA-induced RA mice
We used immunohistochemistry assay for COX-2 and MMP-9 to identify the inflammatory response in the synovial tissue of the RA model. As shown in <Figure 3>, the intensity of COX-2 and MMP-9(arrow indicates positive cells) was lower in the LFadministration group than in the vehicletreated group. 
Discussion and Conclusion
Although the complete therapy for RA is still unknown, a common pathological phenomenon in patients with RA is chronic inflammation. Abnormal immune response is relevant to inducing serious joint damage by pro-inflammatory cytokines, MIF, and type II collagen. In the viewpoint of enzyme signals, elevated levels occur mostly in inflamed tissue, whereas unexpressed levels are found in the normal condition. Elevated MMP-9 is also involved in the inflammatory indication [5] .
The inflammatory process of the synovium in RA indicates synovial cell hyperplasia and fibrosis. In addition, excessive expression levels of COX-2 and MMP-9 are also identified in RA. In the present study, we investigated whether LF can regulate RA through the regulation of COX-2 and MMP-9 in vitro and in vivo. Our results showed that LF treatment significantly reduced inflammation in the RA model. In conclusion, we recommend the combination therapy with exercise and biological supplementation for RA. Rehabilitative exercise may be effective for patients with RA, and the prescription against RA demand excluding these risk factors in the long term. 
